Medinotec (MDNC) EBITDA Margin Growth (3y) (2025 - 2026)
Medinotec (MDNC) EBITDA Margin Growth (3y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.86 Bn | 175.56 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 108.31 Bn | 99.09 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 48.25 Bn | 44.58 Bn | 1.29 Bn | -283.00 |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 1,505.00 |
| 7 | GE HealthCare Technologies | 28.05 Bn | 25.76 Bn | 1.98 Bn | -184.00 |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -763.00 |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | -299.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -299.00 |
| Feb 28, 2026 | 108.00 |
| Nov 30, 2025 | 1,521.00 |
| Aug 31, 2025 | 14,335.00 |
| May 31, 2025 | 3,743.00 |
| Feb 28, 2025 | 8,789.00 |